DDD Stock Analysis: 3D Systems | NYSE
Computer Hardware | NYSE, USA | Market Cap: 588m USD | 12M Return: 24.9% | US88554D2053 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 6.87M
Qual. Beats: 0
Rev. Trend: -98.2%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
3D Systems Corporation (NYSE: DDD) is a global provider of 3D printing and digital manufacturing solutions, operating across the Americas, Europe, the Middle East, Africa, Asia Pacific, and Oceania. The company is organized into two reportable segments: Healthcare Solutions and Industrial Solutions. Its technology portfolio spans multiple 3D printing methods, including stereolithography (SLA), selective laser sintering, direct metal printing, MultiJet printing, and ColorJet printing, supported by a range of print materials such as plastics, nylon, metals, composites, elastomers, wax, and biocompatible materials.
Beyond printers and materials, the company offers digital design tools (software, scanners, haptic devices) and software platforms like 3D Sprint, 3DXpert, and the Oqton manufacturing operating system for managing additive manufacturing workflows. It also provides maintenance, training, and advanced manufacturing services. Its customer base spans industries such as healthcare, dental, automotive, aerospace, defense, energy, electronics, semiconductors, and education, reached through a direct sales force, channel partners, and distributors. Founded in 1986 and headquartered in Rock Hill, South Carolina, 3D Systems is a small-cap company classified within the Industrials sector.
- Healthcare revenue growth led by dental and bioprinting demand
- Industrial segment weakness pressures margins amid intense additive manufacturing competition
- Divestiture proceeds accelerate debt paydown and strengthen capital allocation flexibility
| Net Income: -54.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.12 > 0.02 and ΔFCF/TA 2.59 > 1.0 |
| NWC/Revenue: 66.56% < 20% (prev 60.20%; Δ 6.36% < -1%) |
| CFO/TA -0.09 > 3% & CFO -49.5m > Net Income -54.9m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 3.40 > 1.5 & < 3 |
| Outstanding Shares: last quarter (149.0m) vs 12m ago 15.60% < -2% |
| Gross Margin: 33.36% > 18% (prev 35.08%; Δ -1.72% > 0.5%) |
| Asset Turnover: 69.03% > 50% (prev 70.31%; Δ -1.28% > 0%) |
| Interest Coverage Ratio: -4.97 > 6 (EBIT TTM -40.8m / Interest Expense TTM 8.20m) |
| A: 0.48 (Total Current Assets 365.6m - Total Current Liabilities 107.6m) / Total Assets 535.2m |
| B: -2.52 (Retained Earnings -1.35b / Total Assets 535.2m) |
| C: -0.07 (EBIT TTM -40.8m / Avg Total Assets 561.5m) |
| D: 1.05 (Book Value of Equity 273.6m / Total Liabilities 261.7m) |
| Altman-Z'' = -4.45 = D |
| DSRI: 0.88 (Receivables 80.2m/97.1m, Revenue 387.6m/413.3m) |
| GMI: 1.05 (GM 35.08% / 33.36%) |
| AQI: 0.90 (AQ_t 0.13 / AQ_t-1 0.15) |
| SGI: 0.94 (Revenue 387.6m / 413.3m) |
| TATA: -0.01 (NI -54.9m - CFO -49.5m) / TA 535.2m) |
| Beneish M = -3.19 (Cap -4..+1) = AA |
As of September 24, 2026, the stock is trading at USD 3.51 with a total of 2,219,889 shares traded. Over the past week, the price has changed by +11.78%, over one month by +12.50%, over three months by +11.78% and over the past year by +24.91%.
Current recommended Stop Loss: 3.00 (which is 14.5% or 2.3 ATR below the current price).
3D Systems has received a consensus analysts rating of 3.50. Therefore, it is recommended to hold DDD.
- StrongBuy: 1
- Buy: 0
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 5.5 | 56.7% |
P/E Forward = 22.5225
P/S = 1.5173
P/B = 1.9071
P/EG = 0.8503
Revenue TTM = 387.6m USD
EBIT TTM = -40.8m USD
EBITDA TTM = -20.0m USD
Long Term Debt = 86.4m USD (from longTermDebt, last fiscal year)
Short Term Debt = 13.2m USD (from shortTermDebt, last quarter)
Debt = 162.7m USD (from shortLongTermDebtTotal, last quarter) + Leases 53.4m
Net Debt = 34.7m USD (calculated: Debt 162.7m - CCE 128.0m)
Enterprise Value = 622.9m USD (588.2m + Debt 162.7m - CCE 128.0m)
Interest Coverage Ratio = -4.97 (Ebit TTM -40.8m / Interest Expense TTM 8.20m)
EV/FCF = -10.10x (Enterprise Value 622.9m / FCF TTM -61.7m)
FCF Yield = -9.90% (FCF TTM -61.7m / Enterprise Value 622.9m)
FCF Margin = -15.91% (FCF TTM -61.7m / Revenue TTM 387.6m)
Net Margin = -14.15% (Net Income TTM -54.9m / Revenue TTM 387.6m)
Gross Margin = 33.36% ((Revenue TTM 387.6m - Cost of Revenue TTM 258.3m) / Revenue TTM)
Gross Margin QoQ = 35.80% (prev 35.42%)
Tobins Q-Ratio = 1.16 (Enterprise Value 622.9m / Total Assets 535.2m)
Interest Expense / Debt = 5.04% (Interest Expense 8.20m / Debt 162.7m)
Taxrate = 33.23% (14.9m / 44.8m)
NOPAT = -27.2m (EBIT -40.8m * (1 - 33.23%)) [loss with tax shield]
Current Ratio = 3.40 (Total Current Assets 365.6m / Total Current Liabilities 107.6m)
Debt / Equity = 0.59 (Debt 162.7m / totalStockholderEquity, last quarter 273.6m)
Debt / EBITDA = -1.74 (negative EBITDA) (Net Debt 34.7m / EBITDA -20.0m)
Debt / FCF = -0.56 (negative FCF - burning cash) (Net Debt 34.7m / FCF TTM -61.7m)
Total Stockholder Equity = 242.3m (last 4 quarters mean from totalStockholderEquity)
RoA = -9.77% (Net Income -54.9m / Total Assets 535.2m)
RoE = -22.63% (Net Income TTM -54.9m / Total Stockholder Equity 242.3m)
RoCE = -12.40% (EBIT -40.8m / Capital Employed (Equity 242.3m + L.T.Debt 86.4m))
RoIC = -6.46% (negative operating profit) (NOPAT -27.2m / Invested Capital 421.5m)
WACC = 14.28% (E(588.2m)/V(750.8m) * Re(17.30%) + D(162.7m)/V(750.8m) * Rd(5.04%) * (1-Tc(0.33)))
Discount Rate = 17.30% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 39.91 | Cagr: 4.89%
[DCF] Fair Price = unknown (Cash Flow -61.7m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.78 | # QB: 0
Revenue Correlation: -98.16 | Revenue CAGR: -9.75% | SUE: 0.19 | # QB: 0
EPS current Quarter (2026-09-30): EPS=-0.04 | Chg30d=+19.05% | Revisions=+40% | Analysts=4
EPS current Year (2026-12-31): EPS=-0.14 | Chg30d=+3.45% | Revisions=+0% | GrowthEPS=+62.2% | GrowthRev=+1.7%
EPS next Year (2027-12-31): EPS=-0.12 | Chg30d=+1.96% | Revisions=+0% | GrowthEPS=+10.7% | GrowthRev=+4.3%
[Analyst] Revisions Ratio: +15% (up=6, down=4)